NAC could also preserve the expression level of PGC1a and SirT1 (Supplementary Figure S2C), which further supports the role of SirT1/PGC1a in the treating effect of NAC in dealing with hepatic steatosis. The gene discussed is PPARGC1A; the disease is fatty liver disease.